Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir prophylaxis duration in NHL
NCT02585947Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir in hepatitis B (HBV), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
tenofovir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02585947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02585947.